United Therapeutics Corp.
(NASDAQ : UTHR)

( )
UTHR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.19%178.886.2%$86.86m
AMRNAmarin Corporation Plc Sponsored ADR
-5.40%16.831.8%$86.22m
SAGESAGE Therapeutics, Inc.
-2.72%163.418.8%$71.51m
PRGOPerrigo Co. Plc
-0.18%49.586.8%$70.66m
ICPTIntercept Pharmaceuticals, Inc.
-1.71%84.9418.6%$67.92m
JAZZJazz Pharmaceuticals Plc
-0.60%138.332.3%$64.12m
UTHRUnited Therapeutics Corporation
-3.03%87.9014.3%$58.52m
ZYNEZynerba Pharmaceuticals Inc
-6.27%14.518.3%$47.23m
ICLRICON Plc
-0.14%137.284.1%$43.66m
MNKMallinckrodt Plc
-11.24%13.0321.0%$39.11m
CTLTCatalent Inc
0.04%45.392.4%$37.97m
MDCOMedicines Company
3.76%34.2321.8%$35.99m
PCRXPacira Pharmaceuticals, Inc.
-0.94%43.3210.5%$35.63m
HZNPHorizon Pharma plc
-1.90%25.346.7%$34.69m
AXSMAxsome Therapeutics, Inc.
-1.65%22.702.1%$30.47m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.